"Father of Tamoxifen" to Join MD Anderson

The University of Texas MD Anderson Cancer Center is pleased to announce that one of the world's preeminent experts in breast cancer research and treatment, V. Craig Jordan, Ph.D., will join the institution's efforts to end cancer.  Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives. 
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news